Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Barbara Kopf
Observed names:
B Kopf,
B. Kopf,
BARBARA KOPF
Institution:
Istituto Oncologico della Svizzera Italiana
Observed institutions:
Ospedale "Santa Maria delle Croci" di Ravenna,
Ospedale San Giovanni Bellinzona,
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori,
Ospedale G.B. Morgagni - L.Pierantoni,
Istituto Oncologico Romagnolo,
Istituto Oncologico della Svizzera Italiana
show all 6
OpenAlex ID:
A5000266863
Chromogranin A predicts outcome in prostate cancer patients treated with abiraterone
2014
·
Salvatore Luca Burgio
, Vincenza Conteduca
, et al.
·
Endocrine Related Cancer
·
70
Evaluation of Extensive Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Epithelial Ovarian Cancer
2012
·
Luca Ansaloni
, Vanni Agnoletti
, et al.
·
International Journal of Gynecological Cancer
·
68
Computer-aided diagnosis of melanocytic lesions.
2005
·
Ignazio Stanganelli
, Aldo Brucale
, et al.
·
PubMed
·
52
A randomized study comparing filgrastim versus lenograstim versus molgramostim plus chemotherapy for peripheral blood progenitor cell mobilization
2006
·
B Kopf
, U De Giorgi
, et al.
·
Bone Marrow Transplantation
·
44
High-dose chemotherapy for triple negative breast cancer
2006
·
U. De Giorgi
, G. Rosti
, et al.
·
Annals of Oncology
·
42
PDF
The MITO CERV-2 trial: A randomized phase II study of cetuximab plus carboplatin and paclitaxel, in advanced or recurrent cervical cancer
2019
·
Sandro Pignata
, Giovanni Scambia
, et al.
·
Gynecologic Oncology
·
34
PDF
The emerging role of anti-angiogenic therapy in ovarian cancer
2014
·
VINCENZA CONTEDUCA
, BARBARA KOPF
, et al.
·
International Journal of Oncology
·
21
PDF
Prognostic Role of Systemic Inflammatory Indexes in Germ Cell Tumors Treated With High-Dose Chemotherapy
2020
·
Maria Concetta Cursano
, Barbara Kopf
, et al.
·
Frontiers in Oncology
·
19
PDF
Locally advanced ovarian carcinoid.
2005
·
B Kopf
, G Rosti
, et al.
·
PubMed
·
13
A Phase II Study of a Dose-Density Regimen With Fluorouracil, Epirubicin, and Cyclophosphamide on Days 1 and 4 Every 14 Days With Filgrastim Support Followed by Weekly Paclitaxel in Women With Primary Breast Cancer
2015
·
Elisabetta Pietri
, Daniele Andreis
, et al.
·
The Oncologist
·
10
Innovative Therapy for Patients with Brain Metastases: Oral Treatments
2004
·
B. Kopf
, U. De Giorgi
, et al.
·
Journal of Chemotherapy
·
6
Feasibility of radiotherapy after high-dose dense chemotherapy with epirubicin, preceded by dexrazoxane, and paclitaxel for patients with high-risk Stage II-III breast cancer
2006
·
Ugo De Giorgi
, Massimo Giannini
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
5
Effect of angio-echography with a second-generation contrast agent to assess tumor response to imatinib treatment in patients with advanced gastrointestinal stromal tumor (GIST): Comparison with computerized tomography (CT)
2004
·
U. De Giorgi
, C. Aliberti
, et al.
·
Journal of Clinical Oncology
·
5
Unilateral retinal detachment as the initial sign of lung adenocarcinoma.
2007
·
B Kopf
, D Ercolani
, et al.
·
PubMed
·
4
Lack of activity of imatinib in two cases of KIT+ retroperitoneal liposarcoma.
2007
·
Barbara Kopf
, Paolo Bernardeschi
, et al.
·
PubMed
·
1
Adjuvant high-dose dense chemotherapy: Epirubicin-dexrazoxane and paclitaxel with peripheral blood progenitor cell (PBPC) support in high risk stage II-IIIA breast cancer (phase II trial)
2005
·
G. L. Frassineti
, U. de Giorgi
, et al.
·
Journal of Clinical Oncology
·
1
Computer-Aided Diagnosis Of Melanocytic Lesions And Comparison With Human Operators
2004
·
I. Stanganelli
, A. Brucale
, et al.
·
Melanoma Research
·
1
Minimally invasive, robotic-assisted resection of abdominal wall tumors: a case series
2026
·
Johannes Maria Alberto Toti
, Ramon Pini
, et al.
·
Frontiers in Surgery
PDF
Early response assessment and bone flare phenomenon on 18F-fluorocholine positron emission tomography/computed tomography (FCH-PET/CT) in patients (pts) with metastatic castration-resistant prostate cancer (CRPC) treated with abiraterone acetate.
2013
·
Salvatore Luca Burgio
, Federica Matteucci
, et al.
·
Journal of Clinical Oncology
Multi-Cycle High-Dose Chemotherapy with TI-CE Regimen for Patients with Relapsed/Refractory Germ Cell Tumors – a Single Institution Experience
2012
·
U. De Giorgi
, G. Rosti
, et al.
·
Annals of Oncology
Effect of neutropenia with adjuvant epirubicin-CMF on survival in patients with node-negative or 1 to 3 node-positive rapidly proliferating breast cancer.
2011
·
B. Kopf
, E. Scarpi
, et al.
·
Journal of Clinical Oncology
Intervention model for cancer control in a low-income African area.
2011
·
N. Masalu
, A. Farolfi
, et al.
·
Journal of Clinical Oncology
Multiple cycles of PBPC-supported high-dose carboplatin and paclitaxel following mobilization with epirubicin and cisplatin are feasible but ineffective in treating patients with advanced non-small cell lung cancer
2007
·
U De Giorgi
, G Rosti
, et al.
·
Bone Marrow Transplantation
Chemioterapia ad alte dosi (ongoing trials)
2001
·
Gianantonio Rosti
, Alberto H. Cariello
, et al.
·
Tumori
Show more works
View as search
Works count:
24
Citation count:
396
H-index:
10
I10-index:
10
Year
Topic
Type